| 期 |
标题 |
文件 |
| 卷 95, 编号 12 (2023) |
Molecular mechanisms of the effect of standardized placental hydrolysate peptides on mitochondria functioning |
(Rus)
|
|
Torshin I., Gromova O., Tikhonova O., Chuchalin A.
|
| 卷 95, 编号 12 (2023) |
Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint |
(Rus)
|
|
Mazurov V., Belyaeva I., Trofimov E., Itskovich I., Burulev A.
|
| 卷 95, 编号 12 (2023) |
Point-of-Care Blood Glucose Testing: Post-Market Performance Assessment of the Accu-Chek Inform II Hospital-Use Glucose Meter |
(Rus)
|
|
Petryaykina E., Mayanskiy N., Demina E., Karamysheva I., Gorst K., Timofeev A.
|
| 卷 95, 编号 12 (2023) |
Application of HS221GI in treatment of influenza and ARVI in adults: a new approach – managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial |
(Rus)
|
|
Malyavin A., Bagaeva M., Kalyuzhin O.
|
| 卷 95, 编号 12 (2023) |
Real-world experience with netakimab in the treatment of spondyloarthritis |
(Rus)
|
|
Meshkov A., Vorobyeva N., Ostapenko V., Pykhtina V., Ruzanova V., Perlova O., Kordyukova I., Naumov A., Khovasova N., Tkacheva O.
|
| 卷 95, 编号 12 (2023) |
Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients |
(Rus)
|
|
Yanushevich O., Maev I., Krikheli N., Levchenko O., Galeeva J., Starikova E., Andreev D., Sokolov P., Fomenko A., Devkota M., Andreev N., Zaborovsky A., Evdokimov V., Tsaregorodtsev S., Ilina E., Govorun V., Bely P., Sabelnikova E., Solodov A., Cheremushkin S., Shaburov R., Kebina A.
|
| 卷 95, 编号 11 (2023) |
Features of the course of COVID-19 in patients with type 2 diabetes mellitus |
(Rus)
|
|
Karaseva E., Martynov V., Filatova T., Maleev V., Grishin V., Pronin N., Verbitskaya E., Popova V.
|
| 卷 95, 编号 11 (2023) |
Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C |
(Rus)
|
|
Nozhkin M., Lioznov D., Antonova T., Gorchakova O., Goldstein E., Popova M., Shneyder T.
|
| 卷 95, 编号 11 (2023) |
The possibilities of impulse oscillometry in the diagnosis of the lung function disorders after COVID-19 |
(Rus)
|
|
Savushkina O., Astanin P., Nekludova G., Avdeev S., Zaytsev A.
|
| 卷 95, 编号 11 (2023) |
Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults |
(Rus)
|
|
Zhdanov K., Maltsev O., Kasyanenko K., Kozlov K., Sukachev V., Lvov N., Sharabkhanov V., Litvinov A.
|
| 卷 95, 编号 11 (2023) |
Efficacy and safety of topical combination therapy in patients with acute otitis externa |
(Rus)
|
|
Gurov A., Kriukov A., Shadrin G., Izotova G., Zotova P.
|
| 卷 95, 编号 11 (2023) |
Acute bronchitis – modern possibilities of mucactive therapy |
(Rus)
|
|
Zaitsev A., Filon E., Storozheva Y.
|
| 卷 95, 编号 11 (2023) |
Potential of azoximere bromide for treatment of patients with acute inflammatory and infectious upper respiratory diseases |
(Rus)
|
|
Svistushkin V., Nikiforova G., Eremeeva K., Dekhanov A., Kochetkov P.
|
| 卷 95, 编号 11 (2023) |
The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial |
(Rus)
|
|
Nikiforov V., Petrov V., Stremoukhov A., Avdeeva M., Shvarts Y., Kravchenko I., Nikolaeva I., Ushakova S., Belousova O., Eremina N., Teplykh S., Mel'nikova E., Kostinа N.
|
| 卷 95, 编号 10 (2023) |
Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus |
(Rus)
|
|
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Tarbaeva N., Korneluk A., Kalashnikov V., Shestakova M., Mokrysheva N.
|
| 卷 95, 编号 10 (2023) |
Ala54Thr polymorphism of the fatty acid transporter gene (FABP2) in patients with type 2 diabetes mellitus in Yakutia |
(Rus)
|
|
Sydykova L., Pavlova N., Bochurov A., Alekseev V., Krylov A., Kurtanov K., Shestakova M.
|
| 卷 95, 编号 10 (2023) |
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial |
(Rus)
|
|
Kalyuzhin O., Gorelov A., Malyavin A., Zaytsev A., Esaulenko E., Novak K., Bykov A.
|
| 卷 95, 编号 9 (2023) |
Hemostasis disorders in patients with systemic AL-amyloidosis |
(Rus)
|
|
Rekhtina I., Khyshova V., Zozulya N., Dvirnyk V., Mendeleyeva L.
|
| 卷 95, 编号 9 (2023) |
Relationship between the pain severity, use of non-steroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities |
(Rus)
|
|
Okisheva E., Mironova O., Berdysheva M., Pyatigorets E., Krivova N., Kurnosova A., Elizarov M., Smetanin S., Lychagin A., Fomin V.
|
| 卷 95, 编号 9 (2023) |
Five-year dynamics adrenergic reactivity of erythrocytes after radio-frequency sympathic denervation of renal arteries in patients with resistant arterial hypertension |
(Rus)
|
|
Rebrova T., Falkovskaya A., Afanasiev S., Mordovin V., Zyubanova I., Muslimova E.
|
| 卷 95, 编号 9 (2023) |
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease |
(Rus)
|
|
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
|
| 卷 95, 编号 9 (2023) |
Possibilities of instrumental determination of volemic status in patients with acute decompensation of chronic heart failure |
(Rus)
|
|
Syrkhaeva A., Nasonova S., Zhirov I., Khalilova U., Shirkin A., Shariya M., Tereshchenko S.
|
| 卷 95, 编号 9 (2023) |
A clinical and economic analysis of the use of dapagliflozin in patients with chronic heart failure in the entire spectrum of left ventricular ejection fraction in the Russian Federation |
(Rus)
|
|
Nedogoda S., Tereshchenko S., Zhirov I., Salasyuk A., Barykina I., Lutova V., Popova E.
|
| 卷 95, 编号 8 (2023) |
Opportunities to improve the prognosis of the course of COVID-19 for at-risk patients |
(Rus)
|
|
Tavlueva E., Slyusareva O., Panfilova A., Markarov A.
|
| 卷 95, 编号 8 (2023) |
Cardiovascular risk factors in patients with ulcerative colitis |
(Rus)
|
|
Bicbavova G., Drapkina O., Livzan M., Lisyutenko N., Romanyuk A.
|
| 卷 95, 编号 8 (2023) |
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins |
(Rus)
|
|
Tsygankova O., Evdokimova N., Timoshchenko O., Latyntseva L.
|
| 卷 95, 编号 8 (2023) |
Comparison of the effectiveness of rabeprazole original and generic products in the monotherapy of gastroesophageal reflux disease |
(Rus)
|
|
Krapivnaia O.
|
| 卷 95, 编号 8 (2023) |
Mild post-COVID syndrome in young patients |
(Rus)
|
|
Ivchenko G., Lobzhanidze N., Rusina D., Denisova E., Ivchenko A.
|
| 卷 95, 编号 8 (2023) |
Long-term probiotic administration for irritable bowel syndrome: a legal need |
(Rus)
|
|
Solovyeva O., Nekrasova A., Topalova I., Ponomarenko V., Tsurtsumiia D., Ilyashevich I.
|
| 卷 95, 编号 8 (2023) |
Particularities of arterial stiffness dynamics on the background of breast cancer chemotherapy |
(Rus)
|
|
Yushchuk E., Medvedeva E., Filonenko D., Ivanova S., Zhukova L., Sapunova D.
|
| 卷 95, 编号 8 (2023) |
Drug therapy’s new options in the treatment of the severe irritable bowel syndrome |
(Rus)
|
|
Makarova A., Ruchkina I., Diukova G., Romashkina N., Indejkina L., Degterev D., Parfenov A.
|
| 卷 95, 编号 8 (2023) |
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease |
(Rus)
|
|
Goncharov A., Sasunova A., Pilipenko V., Isakov V.
|
| 卷 95, 编号 8 (2023) |
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy |
(Rus)
|
|
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
|
| 卷 95, 编号 8 (2023) |
The role of structure-modifying agents in the treatment of back pain |
(Rus)
|
|
Shuteeva T.
|
| 卷 95, 编号 7 (2023) |
Features of the course and adverse events risk of coronavirus infection COVID-19 in hematological diseases (data from the CHRONOS19 register for the Primorsky Territory, intermediate stage) |
(Rus)
|
|
Talko A., Nevzorova V., Dubov V., Muzychenko N., Gurbanov E., Dubov S., Beniova S., Simakova A.
|
| 卷 95, 编号 7 (2023) |
The survival prediction of hospitalized patients with COVID-19: the role of chitotriosidase level in peripheral blood |
(Rus)
|
|
Schelkanovtseva E., Isaev G., Mironova O., Balakhonov A., Skvortsov A., Nagornov I., Suvorov A., Fomin V., Panferov A.
|
| 卷 95, 编号 7 (2023) |
Association between cardio-ankle vascular index and markers of thrombosis in hospitalized patients COVID-19 |
(Rus)
|
|
Podzolkov V., Bragina A., Tarzimanova A., Ogibenina E., Shvedov I., Ivannikov A., Megeneishvili N., Sutulova A.
|
| 卷 95, 编号 7 (2023) |
Adherence to treatment of hematological malignancies patients with anxiety and depression |
(Rus)
|
|
Vybornykh D., Moiseeva T., Gemdzhian E., Gaponova T., Esina L., Kolgaeva E., Novikova D.
|
| 卷 95, 编号 7 (2023) |
Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure |
(Rus)
|
|
Vitsenya M., Potekhina A., Gavryushina S., Ibragimova N., Stukalova O., Masenko V., Sharf T., Ageev F.
|
| 卷 95, 编号 7 (2023) |
Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study) |
(Rus)
|
|
Fomina D., Fedosenko S., Bobrikova E., Chernov A., Mukhina O., Lebedkina M., Karaulov A., Nurtazina A., Lysenko M.
|
| 卷 95, 编号 9 (2023) |
Effect of dapagliflozin on the dynamics of magnetic resonance imaging in patients with heart failure and atrial fibrillation |
(Rus)
|
|
Saipudinova K., Uskach T., Shariya M., Ustyuzhanin D., Dobrovolskaya S., Tereshchenko S.
|
| 卷 95, 编号 6 (2023) |
Study of urinary markers of different podocytopathies by proteomic analysis |
(Rus)
|
|
Vinogradov A., Chebotareva N., Bugrova A., Brzhozovskiy A., Krasnova T., Nasibullina K., Kononikhin A., Moiseev S.
|
| 卷 95, 编号 6 (2023) |
Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy |
(Rus)
|
|
Kakhsurueva P., Kamyshova E., Bobkova I., Stavrovskaya E., Rudenko T., Andreeva E.
|
| 卷 95, 编号 6 (2023) |
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease |
(Rus)
|
|
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
|
| 卷 95, 编号 6 (2023) |
Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy |
(Rus)
|
|
Yurova V., Kozlovskaya N., Bobrova L., Kozlov L., Andina S., Demyanova K.
|
| 卷 95, 编号 6 (2023) |
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus |
(Rus)
|
|
Murkamilov I., Aitbaev K., Fomin V.
|
| 卷 95, 编号 6 (2023) |
Potential for infusion correction of COVID-19-associated endotheliopathy |
(Rus)
|
|
Simutis I., Ratnikov V., Scheglov A., Nikolaeva O., Boyarinov G., Sapegin A., Gaikovaya L., Evteeva D., Zamyatina K.
|
| 卷 95, 编号 6 (2023) |
Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study |
(Rus)
|
|
Lebedkina M., Fomina D., Mutovina Z., Mаrkina U., Bogomolov P., Chulanov V., Lysenko M., Alexeeva E.
|
| 卷 95, 编号 5 (2023) |
Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk |
(Rus)
|
|
Gerasimova E., Popkova T., Shalygina M., Kirillova I., Gerasimova D., Glukhova S., Nasonov E.
|
| 卷 95, 编号 5 (2023) |
Long-term use of glucocorticoids in patients with active rheumatoid arthritis: therapeutic "freeze frame" |
(Rus)
|
|
Gordeev A., Matyanova E., Galushko E.
|
| 卷 95, 编号 5 (2023) |
Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy |
(Rus)
|
|
Eliseev M., Zheliabina O., Kirillova I., Korsakova Y.
|
| 卷 95, 编号 5 (2023) |
Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease |
(Rus)
|
|
Borisova A., Lisitsyna T., Veltishchev D., Reshetnyak T.
|
| 卷 95, 编号 5 (2023) |
Physical activity and nutritional status in women with rheumatoid arthritis and sarcopenic phenotype of body composition |
(Rus)
|
|
Dobrovolskaya O., Feklistov A., Demin N., Kozyreva M., Toroptsova N.
|
| 卷 95, 编号 5 (2023) |
A new integral enthesial-comorbididity index of psoriatic arthritis activity |
(Rus)
|
|
Korsakova Y., Korotaeva T., Loginova E., Gubar E., Vorobyeva L., Glukhova S., Nasonov E.
|
| 卷 95, 编号 5 (2023) |
Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients |
(Rus)
|
|
Reshetnyak T., Lisitsyna T., Cheldieva F., Shumilova A., Glukhova S., Starovoytova M., Seredavkina N., Desinova O., Verizhnikova Z., Nasonov E.
|
| 卷 95, 编号 5 (2023) |
The structure of post/long COVID fatigue syndrome. Prospects for correction |
(Rus)
|
|
Kuznetsova P., Tanashyan M., Raskurazhev A., Zaslavskaya K.
|
| 卷 95, 编号 4 (2023) |
Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate |
(Rus)
|
|
Soboleva G., Minasyan A., Gaman S., Rogoza A., Molina L., Soboleva T., Shariya M., Ternovoy S., Karpov Y.
|
| 卷 95, 编号 4 (2023) |
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease |
(Rus)
|
|
Rasskazova M., Vorobyev S., Butova H.
|
| 卷 95, 编号 4 (2023) |
Endoscopic and morphometric analysis of the reduction of acute inflammatory process in the gastric mucosa after therapy with Regasthym Gastro |
(Rus)
|
|
Baryshnikova N., Uspenskiy Y., Fominykh Y., Petlenko S., Zaplutanov V., Apryatina V., Krasnov A.
|
| 卷 95, 编号 4 (2023) |
Prognostic value of periprocedural dynamics of left ventricular ejection fraction and subclinical pulmonary congestion in patients with myocardial infarction |
(Rus)
|
|
Timofeeva T., Kobalava Z., Safarova A., Cabello Montoya F.
|
| 卷 95, 编号 4 (2023) |
The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters |
(Rus)
|
|
Pisklova M., Baulina N., Kiselev I., Zateyshchikov D., Favorova O., Chumakova O.
|
| 卷 95, 编号 3 (2023) |
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease |
(Rus)
|
|
Trushenko N., Stoliarevich A., Andriukov B., Nuralieva G., Tsareva N., Lavginova B., Avdeev S.
|
| 卷 95, 编号 3 (2023) |
Clinic and functional features of chronic obstructive pulmonary disease after virus-induced acute exacerbations. |
(Rus)
|
|
Shpagina L., Kotova O., Shpagin I., Karmanovskaya S., Loktin E., Rukavitsyna A., Kuznetsova G., Gerasimenko D., Anikina E.
|
| 卷 95, 编号 3 (2023) |
Interstitial pneumonia with autoimmune features: monocentric prospective study |
(Rus)
|
|
Akulkina L., Shchepalina A., Moiseev A., Brovko M., Sholomova V., Moiseev S.
|
| 卷 95, 编号 3 (2023) |
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases |
(Rus)
|
|
Shchepikhin E., Shmelev E., Ergeshov A., Zaytseva A., Shergina E., Adamovskaya E.
|
| 卷 95, 编号 3 (2023) |
Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis |
(Rus)
|
|
Zaitsev A., Leshchenko I., Esaulova N., Viktorova I.
|
| 卷 95, 编号 3 (2023) |
Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies |
(Rus)
|
|
Antonov V., Ignatova G.
|
| 卷 95, 编号 2 (2023) |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
|
Bordin D., Voynovan I., Sarsenbaeva A., Zaytsev O., Abdulkhakov R., Bakulina N., Bakulin I., Osipenko M., Livzan M., Alekseenko S., Tarasova L., Tarasova G., Bogomolov P., Maev I., Andreev D., Abdulkhakov S., Starostin B., Bakanova N., Kononova A., Kolbasnikov S., Bueverova E., Moreira L., Megraud F., O'Morain C., Perez Nyssen O., Gisbert J.
|
| 卷 95, 编号 2 (2023) |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
(Rus)
|
|
Maev I., Levchenko A., Galeeva J., Andreev D., Osipenko J., Bordin D., Ilyina E.
|
| 卷 95, 编号 2 (2023) |
The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion |
(Rus)
|
|
Baulo E., Belostotsky N., Akhmadullina O., Dbar S., Bykova S., Parfenov A.
|
| 卷 95, 编号 2 (2023) |
The course and clinical manifestations of Peutz–Jeghers syndrome in the Russian population |
(Rus)
|
|
Savelyeva Т., Ponomarenko А., Shelygin Y., Kuzminov А., Vyshegorodtsev D., Loginova А., Pikunov D., Goncharova Е., Likutov А., Mainovskaya О., Tsukanov А.
|
| 卷 95, 编号 2 (2023) |
Features of the upper gastrointestinal tract mucous membrane state in patients with atherosclerosis of the mesenteric arteries |
(Rus)
|
|
Selyanina A., Dolgushina A., Kusnezowa A., Genkel V., Olevskaya E., Nikushkina K., Khikhlova A.
|
| 卷 95, 编号 2 (2023) |
Liver damage in children and adolescents with newly diagnosed celiac disease: clinical and anamnestic, serological and morphological patterns |
(Rus)
|
|
Cherkasova E., Klimov L., Kuryaninova V., Yagupova A., Ivenskaya T., Gliva A.
|
| 卷 95, 编号 2 (2023) |
Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation |
(Rus)
|
|
Gaus O., Livzan M.
|
| 卷 95, 编号 2 (2023) |
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases |
(Rus)
|
|
Sbikina E., Vinnitskaya E., Batskikh S., Sandler Y., Saliev K., Khaimenova T., Bordin D.
|
| 卷 95, 编号 1 (2023) |
New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease |
(Rus)
|
|
Charushin A., Elovikov A., Charushina I.
|
| 卷 95, 编号 1 (2023) |
Risk factors for adverse outcomes in elderly patients with asthma and severe COVID-19 at the hospital and early post-hospital stages |
(Rus)
|
|
Avdeev S., Gaynitdinova V., Pozdniakova A., Vlasenko A., Gneusheva T., Baytemerova I.
|
| 卷 95, 编号 1 (2023) |
Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19 |
(Rus)
|
|
Zhuravleva M., Chulanov V., Gagarina J., Shabalina E.
|
| 卷 95, 编号 1 (2023) |
Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies |
(Rus)
|
|
Roppelt A., Lebedkina M., Chernov A., Kruglova T., Mukhina O., Yukhnovskaya Y., Samedova F., Mаrkina U., Andrenova G., Karaulov A., Lysenko M., Fomina D.
|
| 卷 95, 编号 1 (2023) |
Comorbid status of patients with hypertension |
(Rus)
|
|
Osmanov E., Reshetnikov V., Manyakov R., Garaeva A., Korkmazova L., Demenkova V.
|
| 卷 95, 编号 1 (2023) |
Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy “escape” phenomenon |
(Rus)
|
|
Mikhailova O., Elfimova E., Litvin A., Chazova I.
|
| 卷 95, 编号 1 (2023) |
Clinical and diagnostic value of including PCR blood test in the traditional algorithm for identifying causative agents of infective endocarditis: a cohort study of 124 patients |
(Rus)
|
|
Kotova E., Domonova E., Kobalava Z., Moiseeva A., Pisaryuk A., Silveystrova O., Karaulova J., Akimkin V.
|
| 卷 95, 编号 1 (2023) |
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis |
(Rus)
|
|
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
|
| 卷 95, 编号 1 (2023) |
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study |
(Rus)
|
|
Maev I., Okhlobystina O., Khalif I., Andreev D.
|
| 卷 94, 编号 12 (2022) |
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism) |
(Rus)
|
|
Kosharnaia R., Belaya Z., Zuraeva Z., Michurova M., Kalashnikov V.
|
| 卷 94, 编号 12 (2022) |
Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome |
(Rus)
|
|
Davidov E., Yaskevich R.
|
| 卷 94, 编号 12 (2022) |
Efficacy and safety of the use of alirocumab in real clinical practice |
(Rus)
|
|
Korneva V., Kuznetsova T., Scopets I., Vezikova N.
|
| 卷 94, 编号 12 (2022) |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
(Rus)
|
|
Bordin D., Andreev D., Maev I.
|
| 卷 94, 编号 12 (2022) |
Treatment of toxic hepatitis in COVID-19 patients |
(Rus)
|
|
Maev I., Shaburov R., Pavlov A., Molodova A., Karakozov A., Kazakov S., Lebedeva E., Ivolgin A., Eremin M., Levchenko O.
|
| 卷 94, 编号 12 (2022) |
Vasoprotective effect of effective lipid-lowering therapy in patients with ST-segment elevation myocardial infarction |
(Rus)
|
|
Salyamova L., Khromova A., Kvasova O., Avdeeva I., Borisova N., Korenkova K., Polezhaeva K., Oleynikov V.
|
| 卷 94, 编号 12 (2022) |
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions |
(Rus)
|
|
Toktogulova N., Sultanalieva R., Tuhvatshin R., Kaliev T.
|
| 卷 94, 编号 12 (2022) |
Subclinical markers of liver damage in patients with arterial hypertension and obesity |
(Rus)
|
|
Sadulaeva I., Yushchuk E., Khalikova L., Krikunova O., Trofimenko O., Medvedeva E.
|
| 卷 94, 编号 12 (2022) |
Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 – REGATA) |
(Rus)
|
|
Kropacheva E., Zemlyanskaya O., Krivosheeva E., Panchenko E.
|
| 卷 94, 编号 12 (2022) |
Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties |
(Rus)
|
|
Sinopalnikov A., Rachina S., Vasilyeva I., Pigusova N., Karpova O.
|
| 卷 94, 编号 11 (2022) |
Predictors of severe course of new coronavirus infection (COVID-19): study design |
(Rus)
|
|
Mishchenko T., Ermakova P., Ermakova A., Tseller L., Rogozhkina Y., Verteletskaya M., Burakevich O., Kardashina Z.
|
| 卷 94, 编号 11 (2022) |
Analysis of fatal outcomes of meningococcal infection in adults |
(Rus)
|
|
Zhdanov K., Kovalenko A., Chirsky V., Gusev D., Nalivkina N., Zinserling V., Grigoriev S., Khairutdinova R., Isakov A., Sharabkhanov V.
|
| 卷 94, 编号 11 (2022) |
Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease |
(Rus)
|
|
Ignatova G., Antonov V.
|
| 卷 94, 编号 11 (2022) |
The mechanisms of anti-inflammatory action of enisamium iodide |
(Rus)
|
|
Kareva E., Fedotcheva T., Semeikin A., Kochina N., Krasnoshchok E., Shimanovskii N.
|
| 卷 94, 编号 11 (2022) |
Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial |
(Rus)
|
|
Avdeeva M., Belousova O., Orlova E., Khamitov R., Shvarts Y., Kravchenko I.
|
| 卷 94, 编号 11 (2022) |
A new approach to etiotropic therapy ARVI in children |
(Rus)
|
|
Sabitov A., Kovtun O., Esaulenko E., Sorokin P.
|
| 卷 94, 编号 11 (2022) |
Prospects and possibilities for the treatment of patients with long COVID-19 syndrome |
(Rus)
|
|
Tanashyan M., Raskurazhev A., Kuznetsova P., Bely P., Zaslavskaya K.
|
| 卷 94, 编号 11 (2022) |
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting |
(Rus)
|
|
Kruglova T., Fomina D.
|
| 卷 94, 编号 11 (2022) |
Regional Vascular Center in a COVID-19 pandemic: what changed in 2020 compared to 2019 in patients with ST Elevation Myocardial Infarction? |
(Rus)
|
|
Syrkina A., Ryabov V.
|
| 卷 94, 编号 11 (2022) |
Dynamics of the structure of renal tuberculosis over 20 years |
(Rus)
|
|
Kulchavenya E., Kholtobin D.
|
| 卷 94, 编号 10 (2022) |
Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection |
(Rus)
|
|
Maltsev O., Kasyanenko K., Kozlov K., Zhdanov K., Lapikov I.
|
| 卷 94, 编号 10 (2022) |
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 |
(Rus)
|
|
Maev I., Andreev D., Sokolov P., Fomenko A., Devkota M., Andreev N., Zaborovsky A.
|
| 卷 94, 编号 10 (2022) |
Body composition in sarcopenia in middle-aged individuals |
(Rus)
|
|
Samoilova I., Matveeva M., Khoroshunova E., Kudlay D., Tolmachev I., Spirina L., Mosienko I., Yun V., Trifonova E., Zakharchuk P., Vachadze T., Shuliko L., Galiukova D., Mutalimi V.
|
| 卷 94, 编号 10 (2022) |
Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus |
(Rus)
|
|
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Nikankina l., Kalashnikov V., Shestakova M., Mokrysheva N.
|
| 卷 94, 编号 10 (2022) |
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy |
(Rus)
|
|
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
|
| 卷 94, 编号 10 (2022) |
The role of systemic immune activation in the development of thyroid dysfunction in COVID-19 |
(Rus)
|
|
Kolpakova E., Elfimova A., Nikankina L., Troshina E.
|
| 卷 94, 编号 9 (2022) |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
(Rus)
|
|
Andreev D., Bordin D., Vyuchnova E., Lebedeva E., Dicheva D., Umyarova R., Maev I.
|
| 卷 94, 编号 9 (2022) |
Mechanical circulatory support in refractory cardiogenic shock: retrospective register study |
(Rus)
|
|
Savvinova P., Manchurov V., Haes B., Skrypnik D., Vasilieva E., Shpektor A.
|
| 卷 94, 编号 9 (2022) |
Impact of anxiety disorders on adherence to anticoagulant therapy in patients with atrial fibrillation |
(Rus)
|
|
Fomicheva A., Troshina D., Simonov A., Kopylov P., Andreev D., Volel B.
|
| 卷 94, 编号 9 (2022) |
The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12-month follow-up |
(Rus)
|
|
Safiullina A., Uskach T., Sapelnikov O., Grishin I., Cherkashin D., Amanatova V., Akchurin R., Tereshchenko S.
|
| 卷 94, 编号 9 (2022) |
Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics |
(Rus)
|
|
Podzolkov V., Bragina A., Osadchiy K., Rodionova Y., Djafarova Z., Khalenyan M., Dishkaya S.
|
| 卷 94, 编号 9 (2022) |
Features of vectorcardiograms in patients with hypertension complicated by chronic heart failure with reduced left ventricle ejection fraction |
(Rus)
|
|
Sakhnova T., Blinova E., Yurasova E., Uskach T., Blinova N., Aidu E., Trunov V., Saidova M.
|
| 卷 94, 编号 9 (2022) |
Remote electrocardiogram telemonitoring after endovascular interventions on the coronary arteries |
(Rus)
|
|
Danilushkin Y., Basinkevich A., Shamrina N., Bubnov D., Silvestrova G., Ageev F., Matchin Y.
|
| 卷 94, 编号 9 (2022) |
The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media |
(Rus)
|
|
Vasin A., Mironova O., Fomin V.
|
| 卷 94, 编号 8 (2022) |
Esophagoprotective therapy in patients with erosive esophagitis |
(Rus)
|
|
Bakulina N., Tikhonov S., Topalova Y., Ilchishina T., Vasiliev R.
|
| 卷 94, 编号 8 (2022) |
Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C |
(Rus)
|
|
Grushko I., Romanova E., Tverdokhlebova T., Gapon M., Vodyanitskaya S.
|
| 卷 94, 编号 8 (2022) |
Modification of dietary patterns in patients with non-alcoholic steatohepatitis |
(Rus)
|
|
Sasunova A., Goncharov A., Morozov S., Isakov V.
|
| 卷 94, 编号 8 (2022) |
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity |
(Rus)
|
|
Starikova E., Galeeva J., Andreev D., Sokolov P., Fedorov D., Manolov A., Pavlenko A., Klimina K., Veselovsky V., Zaborovsky A., Evdokimov V., Andreev N., Devkota M., Fomenko A., Khar'kovskii V., Asadulin P., Kucher S., Cheremushkina A., Yanushevich O., Maev I., Krikheli N., Levchenko O., Ilina E., Govorun V.
|
| 卷 94, 编号 8 (2022) |
The study of microcirculation and tissue metabolism as early diagnostic criteria for the risk of diabetic foot development |
(Rus)
|
|
Mkrtumyan A., Zvenigorodskaya L., Shinkin M.
|
| 卷 94, 编号 7 (2022) |
Peculiarities of hemostasis in patients with COVID-19 |
(Rus)
|
|
Kalinskaya A., Dukhin O., Molodtsov I., Anisimova A., Sokorev D., Elizarova A., Sapozhnikova O., Glebova K., Shakhidzhanov S., Spiridonov I., Ataullakhanov F., Shpektor A., Vasilieva E.
|
| 卷 94, 编号 7 (2022) |
New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19 |
(Rus)
|
|
Gorelov A., Kalyuzhin O., Bagaeva M.
|
| 卷 94, 编号 7 (2022) |
Data from the Russian Severe Asthma Registry (RSAR) |
(Rus)
|
|
Belevskiy A., Nenasheva N., Kravchenko N., Makar'iants N., Kuntsev D.
|
| 卷 94, 编号 7 (2022) |
Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life |
(Rus)
|
|
Vinogradova M., Kulagin A., Shmakov R.
|
| 卷 94, 编号 7 (2022) |
Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation |
(Rus)
|
|
Zyryanov S., Dyakov I., Aisanov Z.
|
| 卷 94, 编号 7 (2022) |
Prevalence and clinical associations of iron deficiency in patients with decompensated heart failure, depending on the diagnostic criteria used for iron deficiency |
(Rus)
|
|
Kobalava Z., Lapshin A., Tolkacheva V., Galochkin S.
|
| 卷 94, 编号 7 (2022) |
Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia |
(Rus)
|
|
Chelysheva E., Petrova A., Shukhov O., Bykova A., Nemchenko I., Gurianova M., Tsyba N., Turkina A.
|
| 卷 94, 编号 7 (2022) |
Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT) |
(Rus)
|
|
Ptushkin V., Kunst M., Mitina T., Konstantinova T., Rachkova N., Shelekhova T., Elykomov I., Kuchma G., Farizova K., Vinogradova O., Nikitin E., Pashanov E.
|
| 卷 94, 编号 7 (2022) |
Нospital outcomes of coronary artery bypass grafting in patients with coronary heart disease with previous percutaneous coronary intervention |
(Rus)
|
|
Kremneva L., Suplotov S., Abaturova O., Stognii N., Shalaev S.
|
| 卷 94, 编号 7 (2022) |
Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome |
(Rus)
|
|
Zykov M., Dyachenko N., Velieva R., Kashtalap V., Barbarash O.
|
| 卷 94, 编号 7 (2022) |
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry) |
(Rus)
|
|
Oschepkova E., Aksenova A., Orlovsky A., Chazova I.
|
| 卷 94, 编号 7 (2022) |
Biochemical markers of thrombotic complications in the acute period of ischemic stroke |
(Rus)
|
|
Kochetov A., Lyang O., Zhirova I., Ivoylov O.
|
| 卷 94, 编号 7 (2022) |
Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016–2019 |
(Rus)
|
|
Sagaydak O., Oschepkova E., Chazova I.
|
| 卷 94, 编号 6 (2022) |
Impact of kidney biopsy on the management of patients in the rheumatology department: retrospective study |
(Rus)
|
|
Kokhanchuk V., Skvortsov A., Shchegoleva E., Kuznetsova E., Novikov P., Stoliarevich E., Varshavsky V., Moiseev S., Bulanov N.
|
| 卷 94, 编号 6 (2022) |
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study |
(Rus)
|
|
Milovanova L., Taranova M., Volkov A., Milovanova S., Beketov V.
|
| 卷 94, 编号 6 (2022) |
New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke |
(Rus)
|
|
Tanashyan M., Raskurazhev A., Zaslavskaya K., Kuznetsova P., Merkulova I.
|
| 卷 94, 编号 6 (2022) |
Risk factors of kidney injury in patients with COVID-19 |
(Rus)
|
|
Shchepalina A., Chebotareva N., Kitbalian A., Potapov P., Nartova A., Akulkina L., Brovko M., Sholomova V., Moiseev S.
|
| 卷 94, 编号 6 (2022) |
Evaluation of hemostasis disorders using the thrombodynamic test in patients with chronic glomerulonephritis with nephrotic syndrome |
(Rus)
|
|
Berns A., Sovetnikov E., Chebotareva N., Berns S., Solonkina A., Guliaev S., Kraeva V., Moiseev S.
|
| 卷 94, 编号 6 (2022) |
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
(Rus)
|
|
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
|
| 卷 94, 编号 6 (2022) |
Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs |
(Rus)
|
|
Grechukhina K., Chebotareva N., Zhukova L., Androsova T., Karpov V., Krasnova T.
|
| 卷 94, 编号 6 (2022) |
Remissions and progression of C3 glomerulopathy |
(Rus)
|
|
Karunnaya A., Dobronravov V.
|
| 卷 94, 编号 5 (2022) |
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit |
(Rus)
|
|
Markina U., Fomina D., Lebedkina M., Kruglova T., Chernov A., Zagrebneva A., Mutovina Z., Karaulov A., Alexeeva E., Lysenko M.
|
| 卷 94, 编号 5 (2022) |
Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment |
(Rus)
|
|
Khripun A., Starshinin A., Antipova Y., Lysenko M., Urozhaeva Y., Gavrilenko O., Rusantsova N., Tyazhelnikov A., Tikhonovskaya E., Okolot N., Sokolova M., Fomina D., Simonova E., Kruglova T., Chernov A., Zagrebneva A.
|
| 卷 94, 编号 5 (2022) |
Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results |
(Rus)
|
|
Galushko E., Gordeev A., Matyanova E., Olyunin Y., Nasonov E.
|
| 卷 94, 编号 5 (2022) |
Phenotypes of body composition, physical performance and quality of life in women with rheumatoid arthritis |
(Rus)
|
|
Dobrovolskaya O., Toroptsova N., Feklistov A., Demin N., Sorokina A., Nikitinskaya O.
|
| 卷 94, 编号 5 (2022) |
Activity of ankylosing spondylitis in women within one year after childbirth |
(Rus)
|
|
Krichevskaya O., Dubinina T., Ilinykh E., Glukhova S., Demina A., Andrianova I.
|
| 卷 94, 编号 5 (2022) |
Achievement of clinical-laboratory and ASAS-partial remission in patients with early axial spondyloarthritis according to the ESAC cohort at the 3rd year of follow-up |
(Rus)
|
|
Timokhina D., Dubinina T., Demina A., Krichevskaya O., Erdes S.
|
| 151 - 300 的 549 信息 |
<< < 1 2 3 4 > >>
|
